Gene Tests Could Spare Kidney Cancer Patients from Unnecessary Chemotherapy

Researchers have shown that genomic sequencing can identify which kidney cancer patients actually need aggressive follow-up treatment, potentially sparing others from harmful side effects. The finding could reshape treatment protocols and reduce healthcare costs by eliminating overtreatment in a common cancer type.

Originaltitel: Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma